2013 Editorial.pdf (156.51 kB)
Transparency of reporting in molecular diagnostics
journal contributionposted on 2023-07-26, 13:25 authored by Stephen A. Bustin
The major advances made over the past few years in molecular and cell biology are providing a progressively more detailed understanding of the molecular pathways that control normal processes and become dysregulated in disease. This has resulted in the documentation of numerous genetic, epigenetic, transcriptomic, proteomic and metabolomic biomarkers that promise earlier disease detection, more accurate patient stratification and better prognosis. Furthermore, molecular fingerprinting of diseases can be predictive of drug response and so assist with specific targeting of drugs against disease-associated molecules and function.
Publication titleInternational Journal of Molecular Sciences
- Published version